Descriptio
Alpelisib intermedia 1,1,1-trifluoro-2-(4-methylpyridin-2-yl)propanol, CAS NO.1396893-43-8.Formula hypothetica compositionis fundationis huius est C9H10F3NO eiusque pondus hypotheticum 205,18.
Intermedia nostra Alpelisib est medicamentum clavis in synthesi alpelisib, interrumpens anti-cancri medicamentum ad curationem hormonis receptoris-positivi, aucti epidermalis humani factor receptoris 2-negativi, cancri pectoris antecedens.Intermedia nostra in alpelisib productione munus vitale agunt et magni ponderis sunt processus synthesis chemicae.
Elige Us
JDK facilities productio primae classis et armorum administratione Qualitas, quae stabilitatem API intermediis confirmat.Professional team assure R&D producti.Contra utrumque, CMO & CDMO in foro domestico et internationali quaerimus.